Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers by Vanessa Zhu, Vanessa Zhu, Jürgen Burhenne, Jürgen Burhenne, Johanna Weiss, Johanna Weiss, Mathias Haag, Mathias Haag, Ute Hofmann, Ute Hofmann, Matthias Schwab, Matthias Schwab, Matthias Schwab, Stephan Urban, Stephan Urban, Gerd Mikus, Gerd Mikus, David Czock, David Czock, Walter E. Haefeli, Walter E. Haefeli, Antje Blank, Antje Blank

Connect to this object online.